18F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital.
Jean-Baptiste Le GoubeyCharline LasnonInes NakouriLaure CésaireMichel de PontvilleCatherine NganoaDiane KottlerNicolas AidePublished in: Diagnostics (Basel, Switzerland) (2021)
Treatment monitoring with 18F-FDG PET/CT is more efficient than ceCT and has a greater impact in patient's management.